The Dividend Yield as of November 2024 (TTM) for NGM Biopharmaceuticals, Inc. (NGM) is 0%

According to NGM Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

NGM Biopharmaceuticals, Inc. (NGM) Historical Dividend Yield (quarterly & annually)

How has NGM Dividend Yield performed in the past?

The mean historical Dividend Yield of NGM Biopharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NGM's Dividend Yield was at its highest in in the December 2017 quarter at 0%. The Dividend Yield was at its lowest in in the December 2017 quarter at 0%.

NGM Biopharmaceuticals, Inc. (NGM) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of NGM Biopharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NGM Biopharmaceuticals, Inc. (NGM) Average Dividend Yield

How has NGM Dividend Yield performed in the past?

The current Dividend Yield of NGM Biopharmaceuticals, Inc. (NGM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NGM Biopharmaceuticals, Inc. (NGM) Dividend Yield vs. Peers

How is NGM’s Dividend Yield compared to its peers?

NGM Biopharmaceuticals, Inc.’s Dividend Yield is less than Neoleukin Therapeutics, Inc. (0%), less than Instil Bio, Inc. (0%), less than Achilles Therapeutics plc (0%), less than NextCure, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Erasca, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Keros Therapeutics, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Nkarta, Inc. (0%), less than Lyell Immunopharma, Inc. (0%), less than Generation Bio Co. (0%), less than Sana Biotechnology, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Foghorn Therapeutics Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Cyteir Therapeutics, Inc. (0%), less than Prelude Therapeutics Incorporated (0%), less than Rezolute, Inc. (0%),

Build a custom stock screener for NGM Biopharmaceuticals, Inc. (NGM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NGM Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NGM Biopharmaceuticals, Inc. (NGM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NGM Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.